title: Pharmaceutical Approval Update.
abstract: Evolocumab (Repatha) for patients with hypercholesterolemia whose condition has not been controlled by statins and other therapies; trifluridine/tipiracil (Lonsurf) for metastatic colorectal cancer; and blood coagulation factor VIII (Nuwiq) for adults and children with hemophilia A.
authors.forename: Kunj
authors.initials: K
authors.lastname: Gohil